Acknowledgements
endometrial cancer, Cancer
MARION, ENDOMETRIAL CANCER, CANCER
We thank the patients and their families for participating in this study. The sponsor of the study was Princess Margararet Cancer Centre, University Health Network. Data collection was performed at the Drug Development Program- Phase II at Princess Margaret Cancer Centre. No medical writer was used for the study manuscript. We would like to thank Natalie Stickle for her support depositing the de-identified genomic data of the study in a public repository. This project was supported by the 2019 Career Development Award from the American Society of Clinical Oncology/Conquer Cancer Foundation awarded to S.L. Thank you to the support provided by GSK in this investigator-initiated trial. We would like to thank the Family of Marion Margaret McCormick for their support in endometrial cancer research and the correlative analyses performed as part of this trial. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario and by the Princess Margaret Cancer Foundation. This study was also performed under the auspice of the VENUS (NCT03420118), LIBERATE (NCT03702309), OCTANE (NCT02906943) studies, and supported by the BMO Chair in Precision Cancer Genomics.